Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
POU5F1
|
ENSG00000204531.11 | POU class 5 homeobox 1 |
POU2F3
|
ENSG00000137709.5 | POU class 2 homeobox 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
POU2F3 | hg19_v2_chr11_+_120107344_120107351 | -0.59 | 6.1e-04 | Click! |
POU5F1 | hg19_v2_chr6_-_31138439_31138475 | 0.40 | 2.7e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_153044083 | 6.33 |
ENST00000341611.2
|
SPRR2B
|
small proline-rich protein 2B |
chr1_-_153029980 | 6.08 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chr1_-_153066998 | 5.25 |
ENST00000368750.3
|
SPRR2E
|
small proline-rich protein 2E |
chr1_-_153013588 | 4.66 |
ENST00000360379.3
|
SPRR2D
|
small proline-rich protein 2D |
chr2_-_113594279 | 4.35 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr9_+_132099158 | 3.75 |
ENST00000444125.1
|
RP11-65J3.1
|
RP11-65J3.1 |
chr19_-_50143452 | 3.43 |
ENST00000246792.3
|
RRAS
|
related RAS viral (r-ras) oncogene homolog |
chr1_+_17575584 | 2.71 |
ENST00000375460.3
|
PADI3
|
peptidyl arginine deiminase, type III |
chr20_+_361890 | 2.62 |
ENST00000449710.1
ENST00000422053.2 |
TRIB3
|
tribbles pseudokinase 3 |
chr17_+_62461569 | 2.61 |
ENST00000603557.1
ENST00000605096.1 |
MILR1
|
mast cell immunoglobulin-like receptor 1 |
chr8_+_7752151 | 2.55 |
ENST00000302247.2
|
DEFB4A
|
defensin, beta 4A |
chr20_+_361261 | 2.38 |
ENST00000217233.3
|
TRIB3
|
tribbles pseudokinase 3 |
chr6_+_26183958 | 2.23 |
ENST00000356530.3
|
HIST1H2BE
|
histone cluster 1, H2be |
chr12_+_107712173 | 2.09 |
ENST00000280758.5
ENST00000420571.2 |
BTBD11
|
BTB (POZ) domain containing 11 |
chr1_-_153085984 | 2.05 |
ENST00000468739.1
|
SPRR2F
|
small proline-rich protein 2F |
chr6_-_35656685 | 2.05 |
ENST00000539068.1
ENST00000540787.1 |
FKBP5
|
FK506 binding protein 5 |
chr3_+_130650738 | 1.93 |
ENST00000504612.1
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1 |
chr4_-_139163491 | 1.91 |
ENST00000280612.5
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
chr6_-_35656712 | 1.91 |
ENST00000357266.4
ENST00000542713.1 |
FKBP5
|
FK506 binding protein 5 |
chr6_+_26251835 | 1.88 |
ENST00000356350.2
|
HIST1H2BH
|
histone cluster 1, H2bh |
chr6_-_26124138 | 1.85 |
ENST00000314332.5
ENST00000396984.1 |
HIST1H2BC
|
histone cluster 1, H2bc |
chr19_+_39903185 | 1.83 |
ENST00000409794.3
|
PLEKHG2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
chr6_-_27114577 | 1.83 |
ENST00000356950.1
ENST00000396891.4 |
HIST1H2BK
|
histone cluster 1, H2bk |
chr1_+_228645796 | 1.83 |
ENST00000369160.2
|
HIST3H2BB
|
histone cluster 3, H2bb |
chr9_+_33750667 | 1.82 |
ENST00000457896.1
ENST00000342836.4 ENST00000429677.3 |
PRSS3
|
protease, serine, 3 |
chr9_+_33750515 | 1.80 |
ENST00000361005.5
|
PRSS3
|
protease, serine, 3 |
chr15_+_45406519 | 1.77 |
ENST00000323030.5
|
DUOXA2
|
dual oxidase maturation factor 2 |
chr2_+_174219548 | 1.71 |
ENST00000347703.3
ENST00000392567.2 ENST00000306721.3 ENST00000410101.3 ENST00000410019.3 |
CDCA7
|
cell division cycle associated 7 |
chr2_+_89890533 | 1.65 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
chr6_+_37137939 | 1.61 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
chr8_+_39759794 | 1.57 |
ENST00000518804.1
ENST00000519154.1 ENST00000522495.1 ENST00000522840.1 |
IDO1
|
indoleamine 2,3-dioxygenase 1 |
chr8_+_85618155 | 1.54 |
ENST00000523850.1
ENST00000521376.1 |
RALYL
|
RALY RNA binding protein-like |
chr12_-_10978957 | 1.54 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
chr1_-_153113927 | 1.53 |
ENST00000368752.4
|
SPRR2B
|
small proline-rich protein 2B |
chr12_-_123201337 | 1.52 |
ENST00000528880.2
|
HCAR3
|
hydroxycarboxylic acid receptor 3 |
chr12_-_123187890 | 1.52 |
ENST00000328880.5
|
HCAR2
|
hydroxycarboxylic acid receptor 2 |
chr4_-_39034542 | 1.51 |
ENST00000344606.6
|
TMEM156
|
transmembrane protein 156 |
chr5_-_39270725 | 1.51 |
ENST00000512138.1
ENST00000512982.1 ENST00000540520.1 |
FYB
|
FYN binding protein |
chr2_+_89998789 | 1.51 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr8_+_25316707 | 1.47 |
ENST00000380665.3
|
CDCA2
|
cell division cycle associated 2 |
chr12_-_57634475 | 1.46 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
chr16_+_32077386 | 1.46 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr1_+_152975488 | 1.45 |
ENST00000542696.1
|
SPRR3
|
small proline-rich protein 3 |
chr2_+_210444748 | 1.45 |
ENST00000392194.1
|
MAP2
|
microtubule-associated protein 2 |
chr8_+_25316489 | 1.44 |
ENST00000330560.3
|
CDCA2
|
cell division cycle associated 2 |
chr16_-_79634595 | 1.40 |
ENST00000326043.4
ENST00000393350.1 |
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
chr14_-_107095662 | 1.34 |
ENST00000390630.2
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
chr5_-_39203093 | 1.33 |
ENST00000515010.1
|
FYB
|
FYN binding protein |
chr2_+_90077680 | 1.32 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr17_-_45908875 | 1.32 |
ENST00000351111.2
ENST00000414011.1 |
MRPL10
|
mitochondrial ribosomal protein L10 |
chr14_-_57272366 | 1.32 |
ENST00000554788.1
ENST00000554845.1 ENST00000408990.3 |
OTX2
|
orthodenticle homeobox 2 |
chr1_-_153348067 | 1.32 |
ENST00000368737.3
|
S100A12
|
S100 calcium binding protein A12 |
chr2_-_89521942 | 1.31 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
chr22_+_44319619 | 1.31 |
ENST00000216180.3
|
PNPLA3
|
patatin-like phospholipase domain containing 3 |
chr19_+_52873166 | 1.29 |
ENST00000424032.2
ENST00000600321.1 ENST00000344085.5 ENST00000597976.1 ENST00000422689.2 |
ZNF880
|
zinc finger protein 880 |
chr7_+_18535786 | 1.25 |
ENST00000406072.1
|
HDAC9
|
histone deacetylase 9 |
chr14_-_107083690 | 1.25 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
chr22_+_44319648 | 1.25 |
ENST00000423180.2
|
PNPLA3
|
patatin-like phospholipase domain containing 3 |
chr6_-_11779403 | 1.24 |
ENST00000414691.3
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
chr22_+_21987005 | 1.24 |
ENST00000607942.1
ENST00000425975.1 ENST00000292779.3 |
CCDC116
|
coiled-coil domain containing 116 |
chr12_-_67072714 | 1.22 |
ENST00000545666.1
ENST00000398016.3 ENST00000359742.4 ENST00000286445.7 ENST00000538211.1 |
GRIP1
|
glutamate receptor interacting protein 1 |
chr20_-_54967187 | 1.21 |
ENST00000422322.1
ENST00000371356.2 ENST00000451915.1 ENST00000347343.2 ENST00000395911.1 ENST00000395907.1 ENST00000441357.1 ENST00000456249.1 ENST00000420474.1 ENST00000395909.4 ENST00000395914.1 ENST00000312783.6 ENST00000395915.3 ENST00000395913.3 |
AURKA
|
aurora kinase A |
chr12_+_113344755 | 1.19 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr2_-_89442621 | 1.19 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr2_+_89975669 | 1.19 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
chr2_-_89545079 | 1.18 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
chr11_-_64085533 | 1.15 |
ENST00000544844.1
|
TRMT112
|
tRNA methyltransferase 11-2 homolog (S. cerevisiae) |
chr11_-_64084959 | 1.15 |
ENST00000535750.1
ENST00000535126.1 ENST00000539854.1 ENST00000308774.2 |
TRMT112
|
tRNA methyltransferase 11-2 homolog (S. cerevisiae) |
chr2_-_208030647 | 1.14 |
ENST00000309446.6
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr2_+_90060377 | 1.12 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr15_+_67458357 | 1.12 |
ENST00000537194.2
|
SMAD3
|
SMAD family member 3 |
chr3_-_48594248 | 1.11 |
ENST00000545984.1
ENST00000232375.3 ENST00000416568.1 ENST00000383734.2 ENST00000541519.1 ENST00000412035.1 |
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
chr2_+_105050794 | 1.11 |
ENST00000429464.1
ENST00000414442.1 ENST00000447380.1 |
AC013402.2
|
long intergenic non-protein coding RNA 1102 |
chr7_-_41742697 | 1.09 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
chr7_-_93520259 | 1.09 |
ENST00000222543.5
|
TFPI2
|
tissue factor pathway inhibitor 2 |
chr6_+_26124373 | 1.08 |
ENST00000377791.2
ENST00000602637.1 |
HIST1H2AC
|
histone cluster 1, H2ac |
chr14_-_106830057 | 1.08 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
chr11_+_111126707 | 1.07 |
ENST00000280325.4
|
C11orf53
|
chromosome 11 open reading frame 53 |
chr4_+_5526883 | 1.07 |
ENST00000195455.2
|
C4orf6
|
chromosome 4 open reading frame 6 |
chr10_-_29811456 | 1.07 |
ENST00000535393.1
|
SVIL
|
supervillin |
chr15_-_80263506 | 1.05 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr2_-_188419078 | 1.03 |
ENST00000437725.1
ENST00000409676.1 ENST00000339091.4 ENST00000420747.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr2_-_190044480 | 1.03 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr4_-_159094194 | 1.02 |
ENST00000592057.1
ENST00000585682.1 ENST00000393807.5 |
FAM198B
|
family with sequence similarity 198, member B |
chr7_+_143174966 | 1.02 |
ENST00000408916.1
|
TAS2R41
|
taste receptor, type 2, member 41 |
chr1_-_197115818 | 1.01 |
ENST00000367409.4
ENST00000294732.7 |
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
chr20_+_306177 | 1.01 |
ENST00000544632.1
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr17_-_7307358 | 1.00 |
ENST00000576017.1
ENST00000302422.3 ENST00000535512.1 |
TMEM256
TMEM256-PLSCR3
|
transmembrane protein 256 TMEM256-PLSCR3 readthrough (NMD candidate) |
chr4_-_99578776 | 1.00 |
ENST00000515287.1
|
TSPAN5
|
tetraspanin 5 |
chr7_+_80275953 | 0.99 |
ENST00000538969.1
ENST00000544133.1 ENST00000433696.2 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr10_-_3827417 | 0.98 |
ENST00000497571.1
ENST00000542957.1 |
KLF6
|
Kruppel-like factor 6 |
chr11_-_568369 | 0.97 |
ENST00000534540.1
ENST00000528245.1 ENST00000500447.1 ENST00000533920.1 |
MIR210HG
|
MIR210 host gene (non-protein coding) |
chr3_-_111314230 | 0.97 |
ENST00000317012.4
|
ZBED2
|
zinc finger, BED-type containing 2 |
chr2_+_90108504 | 0.95 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr2_+_234600253 | 0.94 |
ENST00000373424.1
ENST00000441351.1 |
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6 |
chr6_+_34204642 | 0.94 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
chr11_+_125495862 | 0.93 |
ENST00000428830.2
ENST00000544373.1 ENST00000527013.1 ENST00000526937.1 ENST00000534685.1 |
CHEK1
|
checkpoint kinase 1 |
chr6_-_39290316 | 0.93 |
ENST00000425054.2
ENST00000373227.4 ENST00000373229.5 ENST00000437525.2 |
KCNK16
|
potassium channel, subfamily K, member 16 |
chr21_+_10862622 | 0.93 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
chr2_-_188419200 | 0.93 |
ENST00000233156.3
ENST00000426055.1 ENST00000453013.1 ENST00000417013.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr2_+_136343820 | 0.93 |
ENST00000410054.1
|
R3HDM1
|
R3H domain containing 1 |
chr1_-_68962805 | 0.92 |
ENST00000370966.5
|
DEPDC1
|
DEP domain containing 1 |
chr4_-_99578789 | 0.92 |
ENST00000511651.1
ENST00000505184.1 |
TSPAN5
|
tetraspanin 5 |
chr18_+_47088401 | 0.92 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
chr19_-_1132207 | 0.91 |
ENST00000438103.2
|
SBNO2
|
strawberry notch homolog 2 (Drosophila) |
chr11_-_2906979 | 0.90 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr7_-_93520191 | 0.90 |
ENST00000545378.1
|
TFPI2
|
tissue factor pathway inhibitor 2 |
chr1_-_68962782 | 0.90 |
ENST00000456315.2
|
DEPDC1
|
DEP domain containing 1 |
chr22_+_23089870 | 0.89 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
chr3_+_50192537 | 0.89 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr8_-_125577940 | 0.89 |
ENST00000519168.1
ENST00000395508.2 |
MTSS1
|
metastasis suppressor 1 |
chr17_+_38171681 | 0.88 |
ENST00000225474.2
ENST00000331769.2 ENST00000394148.3 ENST00000577675.1 |
CSF3
|
colony stimulating factor 3 (granulocyte) |
chr6_-_108145499 | 0.88 |
ENST00000369020.3
ENST00000369022.2 |
SCML4
|
sex comb on midleg-like 4 (Drosophila) |
chr1_+_6052700 | 0.88 |
ENST00000378092.1
ENST00000445501.1 |
KCNAB2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chr20_-_60982330 | 0.88 |
ENST00000279101.5
|
CABLES2
|
Cdk5 and Abl enzyme substrate 2 |
chr15_-_56209306 | 0.87 |
ENST00000506154.1
ENST00000338963.2 ENST00000508342.1 |
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
chr1_-_149783914 | 0.87 |
ENST00000369167.1
ENST00000427880.2 ENST00000545683.1 |
HIST2H2BF
|
histone cluster 2, H2bf |
chr3_+_50192499 | 0.86 |
ENST00000413852.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr20_+_34556488 | 0.86 |
ENST00000373973.3
ENST00000349339.1 ENST00000538900.1 |
CNBD2
|
cyclic nucleotide binding domain containing 2 |
chr22_-_28197486 | 0.86 |
ENST00000302326.4
|
MN1
|
meningioma (disrupted in balanced translocation) 1 |
chr14_-_106573756 | 0.86 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
chr14_+_32798547 | 0.85 |
ENST00000557354.1
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A kinase (PRKA) anchor protein 6 |
chr14_+_32798462 | 0.85 |
ENST00000280979.4
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
chr3_+_130569592 | 0.84 |
ENST00000533801.2
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1 |
chr11_-_31832581 | 0.84 |
ENST00000379111.2
|
PAX6
|
paired box 6 |
chr22_+_38093005 | 0.84 |
ENST00000406386.3
|
TRIOBP
|
TRIO and F-actin binding protein |
chr6_+_27861190 | 0.83 |
ENST00000303806.4
|
HIST1H2BO
|
histone cluster 1, H2bo |
chr17_+_38171614 | 0.83 |
ENST00000583218.1
ENST00000394149.3 |
CSF3
|
colony stimulating factor 3 (granulocyte) |
chr15_-_72612470 | 0.82 |
ENST00000287202.5
|
CELF6
|
CUGBP, Elav-like family member 6 |
chr6_-_26043885 | 0.82 |
ENST00000357905.2
|
HIST1H2BB
|
histone cluster 1, H2bb |
chr14_-_106610852 | 0.82 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
chr2_+_210444142 | 0.82 |
ENST00000360351.4
ENST00000361559.4 |
MAP2
|
microtubule-associated protein 2 |
chr19_+_926000 | 0.81 |
ENST00000263620.3
|
ARID3A
|
AT rich interactive domain 3A (BRIGHT-like) |
chr5_+_96212185 | 0.81 |
ENST00000379904.4
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr7_-_3083573 | 0.80 |
ENST00000396946.4
|
CARD11
|
caspase recruitment domain family, member 11 |
chr5_+_96211643 | 0.80 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr14_-_106552755 | 0.80 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
chr14_+_79745682 | 0.79 |
ENST00000557594.1
|
NRXN3
|
neurexin 3 |
chr14_-_106494587 | 0.77 |
ENST00000390597.2
|
IGHV2-5
|
immunoglobulin heavy variable 2-5 |
chr15_-_45406385 | 0.77 |
ENST00000389039.6
|
DUOX2
|
dual oxidase 2 |
chr3_-_33686925 | 0.77 |
ENST00000485378.2
ENST00000313350.6 ENST00000487200.1 |
CLASP2
|
cytoplasmic linker associated protein 2 |
chrX_-_106960285 | 0.76 |
ENST00000503515.1
ENST00000372397.2 |
TSC22D3
|
TSC22 domain family, member 3 |
chrX_-_73072534 | 0.76 |
ENST00000429829.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
chr3_+_63428752 | 0.76 |
ENST00000295894.5
|
SYNPR
|
synaptoporin |
chr22_-_27456361 | 0.76 |
ENST00000453934.1
|
CTA-992D9.6
|
CTA-992D9.6 |
chr14_-_106478603 | 0.76 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
chr1_-_40157345 | 0.76 |
ENST00000372844.3
|
HPCAL4
|
hippocalcin like 4 |
chr15_+_63334831 | 0.75 |
ENST00000288398.6
ENST00000358278.3 ENST00000560445.1 ENST00000403994.3 ENST00000357980.4 ENST00000559556.1 ENST00000559397.1 ENST00000267996.7 ENST00000560970.1 |
TPM1
|
tropomyosin 1 (alpha) |
chr3_+_63428982 | 0.75 |
ENST00000479198.1
ENST00000460711.1 ENST00000465156.1 |
SYNPR
|
synaptoporin |
chr6_-_131291572 | 0.75 |
ENST00000529208.1
|
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
chr4_+_5527117 | 0.75 |
ENST00000505296.1
|
C4orf6
|
chromosome 4 open reading frame 6 |
chr12_+_113344811 | 0.75 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr3_+_57882024 | 0.74 |
ENST00000494088.1
|
SLMAP
|
sarcolemma associated protein |
chr13_-_30881134 | 0.74 |
ENST00000380617.3
ENST00000441394.1 |
KATNAL1
|
katanin p60 subunit A-like 1 |
chr2_+_201173667 | 0.74 |
ENST00000409755.3
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like |
chr14_-_106791536 | 0.74 |
ENST00000390613.2
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
chr11_-_31832862 | 0.73 |
ENST00000379115.4
|
PAX6
|
paired box 6 |
chr22_-_24096562 | 0.73 |
ENST00000398465.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr7_-_50860565 | 0.71 |
ENST00000403097.1
|
GRB10
|
growth factor receptor-bound protein 10 |
chr18_+_657578 | 0.71 |
ENST00000323274.10
|
TYMS
|
thymidylate synthetase |
chr11_-_78140882 | 0.70 |
ENST00000513207.2
|
RP11-452H21.4
|
RP11-452H21.4 |
chr3_-_113918254 | 0.70 |
ENST00000460779.1
|
DRD3
|
dopamine receptor D3 |
chr20_+_306221 | 0.70 |
ENST00000342665.2
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr11_-_31832785 | 0.70 |
ENST00000241001.8
|
PAX6
|
paired box 6 |
chr7_-_128049955 | 0.70 |
ENST00000419067.2
ENST00000378717.4 |
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1 |
chr12_-_50419177 | 0.70 |
ENST00000454520.2
ENST00000546595.1 ENST00000548824.1 ENST00000549777.1 ENST00000546723.1 ENST00000427314.2 ENST00000552157.1 ENST00000552310.1 ENST00000548644.1 ENST00000312377.5 ENST00000546786.1 ENST00000550149.1 ENST00000546764.1 ENST00000552004.1 ENST00000548320.1 ENST00000547905.1 ENST00000550651.1 ENST00000551145.1 ENST00000434422.1 ENST00000552921.1 |
RACGAP1
|
Rac GTPase activating protein 1 |
chr4_-_47983519 | 0.70 |
ENST00000358519.4
ENST00000544810.1 ENST00000402813.3 |
CNGA1
|
cyclic nucleotide gated channel alpha 1 |
chrX_-_65259900 | 0.69 |
ENST00000412866.2
|
VSIG4
|
V-set and immunoglobulin domain containing 4 |
chr9_-_36276966 | 0.69 |
ENST00000543356.2
ENST00000396594.3 |
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
chr6_+_27782788 | 0.69 |
ENST00000359465.4
|
HIST1H2BM
|
histone cluster 1, H2bm |
chr1_+_87012753 | 0.69 |
ENST00000370563.3
|
CLCA4
|
chloride channel accessory 4 |
chr16_+_23690138 | 0.69 |
ENST00000300093.4
|
PLK1
|
polo-like kinase 1 |
chr2_-_89327228 | 0.69 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr14_-_107049312 | 0.68 |
ENST00000390627.2
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
chr13_-_36050819 | 0.68 |
ENST00000379919.4
|
MAB21L1
|
mab-21-like 1 (C. elegans) |
chr2_-_89247338 | 0.68 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr6_-_110501200 | 0.68 |
ENST00000392586.1
ENST00000419252.1 ENST00000392589.1 ENST00000392588.1 ENST00000359451.2 |
WASF1
|
WAS protein family, member 1 |
chr7_+_141463897 | 0.68 |
ENST00000247879.2
|
TAS2R3
|
taste receptor, type 2, member 3 |
chr21_+_30502806 | 0.68 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
chr2_+_90211643 | 0.68 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr22_+_23063100 | 0.67 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr16_-_79633799 | 0.67 |
ENST00000569649.1
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
chr4_-_100065419 | 0.67 |
ENST00000504125.1
ENST00000505590.1 |
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide |
chr2_+_196521458 | 0.67 |
ENST00000409086.3
|
SLC39A10
|
solute carrier family 39 (zinc transporter), member 10 |
chr3_-_87040233 | 0.67 |
ENST00000398399.2
|
VGLL3
|
vestigial like 3 (Drosophila) |
chr1_+_116654376 | 0.66 |
ENST00000369500.3
|
MAB21L3
|
mab-21-like 3 (C. elegans) |
chr1_-_26185844 | 0.66 |
ENST00000538789.1
ENST00000374298.3 |
AUNIP
|
aurora kinase A and ninein interacting protein |
chr22_-_24096630 | 0.66 |
ENST00000248948.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr22_-_20367797 | 0.66 |
ENST00000424787.2
|
GGTLC3
|
gamma-glutamyltransferase light chain 3 |
chr4_+_70796784 | 0.65 |
ENST00000246891.4
ENST00000444405.3 |
CSN1S1
|
casein alpha s1 |
chr4_+_41258786 | 0.65 |
ENST00000503431.1
ENST00000284440.4 ENST00000508768.1 ENST00000512788.1 |
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
chr17_+_43213004 | 0.65 |
ENST00000586346.1
ENST00000398322.3 ENST00000592162.1 ENST00000376955.4 ENST00000321854.8 |
ACBD4
|
acyl-CoA binding domain containing 4 |
chr5_-_39425290 | 0.65 |
ENST00000545653.1
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
chrX_-_65259914 | 0.65 |
ENST00000374737.4
ENST00000455586.2 |
VSIG4
|
V-set and immunoglobulin domain containing 4 |
chrX_+_150148976 | 0.65 |
ENST00000419110.1
|
HMGB3
|
high mobility group box 3 |
chr2_+_113816215 | 0.65 |
ENST00000346807.3
|
IL36RN
|
interleukin 36 receptor antagonist |
chr11_+_69455855 | 0.65 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
chr12_-_122240792 | 0.65 |
ENST00000545885.1
ENST00000542933.1 ENST00000428029.2 ENST00000541694.1 ENST00000536662.1 ENST00000535643.1 ENST00000541657.1 |
AC084018.1
RHOF
|
AC084018.1 ras homolog family member F (in filopodia) |
chr6_-_32784687 | 0.64 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
chr19_+_17858509 | 0.64 |
ENST00000594202.1
ENST00000252771.7 ENST00000389133.4 |
FCHO1
|
FCH domain only 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.5 | 2.7 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.5 | 3.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.5 | 2.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.5 | 1.8 | GO:0036269 | swimming behavior(GO:0036269) |
0.5 | 2.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.4 | 1.2 | GO:1900195 | spindle assembly involved in female meiosis I(GO:0007057) positive regulation of oocyte maturation(GO:1900195) |
0.4 | 1.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.4 | 28.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.4 | 1.1 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.3 | 1.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.4 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.3 | 1.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 1.6 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.3 | 0.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.3 | 1.3 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.3 | 0.9 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 2.3 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.3 | 1.4 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.3 | 1.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.3 | 1.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 1.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 1.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 0.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 2.0 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 0.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 1.8 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.2 | 1.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 2.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 5.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.2 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 2.4 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.2 | 1.1 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.2 | 0.9 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.2 | 0.2 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.2 | 0.5 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.2 | 0.7 | GO:0019860 | transformation of host cell by virus(GO:0019087) uracil metabolic process(GO:0019860) |
0.2 | 1.2 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.2 | 0.7 | GO:0050883 | negative regulation of sodium:proton antiporter activity(GO:0032416) musculoskeletal movement, spinal reflex action(GO:0050883) |
0.2 | 0.7 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.2 | 2.6 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.5 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.2 | 0.8 | GO:0030047 | actin modification(GO:0030047) |
0.2 | 1.3 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.2 | 1.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.2 | 0.9 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 1.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 6.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 1.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.1 | GO:0005984 | maltose metabolic process(GO:0000023) disaccharide metabolic process(GO:0005984) |
0.1 | 1.6 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.6 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.1 | 0.6 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.1 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.7 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.9 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 0.5 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 3.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.5 | GO:0071484 | response to high light intensity(GO:0009644) cellular response to light intensity(GO:0071484) |
0.1 | 0.6 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 0.5 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.1 | 0.4 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.1 | 0.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.3 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.1 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.5 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 1.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.6 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 4.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 2.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.3 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
0.1 | 0.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.2 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 3.4 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 14.0 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.4 | GO:0021650 | vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
0.1 | 1.8 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.4 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.1 | 0.4 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.4 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 5.8 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.1 | 0.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.1 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.1 | 0.3 | GO:0035905 | N-terminal peptidyl-lysine acetylation(GO:0018076) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.1 | 0.8 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.1 | 0.3 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.6 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.1 | 1.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 1.6 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.4 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.5 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.1 | 0.6 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 0.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.3 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.1 | 1.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.9 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.4 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.1 | 0.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 4.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.1 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.1 | 0.7 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 0.2 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.1 | 0.3 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 0.3 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.1 | 0.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 2.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.3 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.8 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 1.8 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.1 | 3.5 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 0.2 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 1.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.5 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.2 | GO:2000870 | positive regulation of female gonad development(GO:2000196) regulation of progesterone secretion(GO:2000870) |
0.1 | 0.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.2 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.1 | 0.2 | GO:0032848 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.1 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.1 | 0.4 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.3 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.6 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.9 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.1 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.1 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 1.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.2 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.1 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.7 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.4 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.1 | 0.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.2 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.1 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 1.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.2 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.0 | 1.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.0 | 0.2 | GO:0035549 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) positive regulation of interferon-beta secretion(GO:0035549) |
0.0 | 0.7 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 7.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.0 | 6.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.4 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.0 | 0.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.3 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.0 | 0.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.3 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.0 | 0.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.1 | GO:2000547 | myeloid dendritic cell chemotaxis(GO:0002408) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.0 | 0.2 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 2.1 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 1.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.0 | 0.2 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.0 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.3 | GO:0050966 | neuronal action potential propagation(GO:0019227) detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) action potential propagation(GO:0098870) |
0.0 | 0.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.2 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.0 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.0 | 0.1 | GO:1900157 | positive regulation of osteoclast proliferation(GO:0090290) regulation of bone mineralization involved in bone maturation(GO:1900157) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.0 | 0.1 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.0 | 0.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.1 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.0 | 0.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.2 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.1 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.0 | 0.7 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.0 | 0.8 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.1 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.0 | 0.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.0 | 0.1 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.0 | 0.3 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.0 | 0.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.8 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.5 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.3 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.2 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.0 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.4 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.3 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.3 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 0.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 2.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.0 | 0.1 | GO:0036018 | response to erythropoietin(GO:0036017) cellular response to erythropoietin(GO:0036018) |
0.0 | 0.2 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.0 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.3 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.3 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 0.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.2 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.9 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 2.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) guanine metabolic process(GO:0046098) response to fungicide(GO:0060992) |
0.0 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.1 | GO:1901256 | macrophage colony-stimulating factor production(GO:0036301) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.0 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of coagulation(GO:0050818) regulation of hemostasis(GO:1900046) |
0.0 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.7 | GO:0008284 | positive regulation of cell proliferation(GO:0008284) |
0.0 | 0.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.0 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.0 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 1.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.0 | 0.9 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:1903121 | negative regulation of ribosome biogenesis(GO:0090071) postsynaptic density assembly(GO:0097107) regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.0 | 2.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.0 | 0.3 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.1 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.0 | 0.1 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.5 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.2 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 0.0 | GO:0071338 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
0.0 | 0.2 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
0.0 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.9 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.0 | 0.2 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 2.9 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.3 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 1.4 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.3 | GO:0030097 | hemopoiesis(GO:0030097) hematopoietic or lymphoid organ development(GO:0048534) |
0.0 | 0.1 | GO:0043654 | complement activation, lectin pathway(GO:0001867) recognition of apoptotic cell(GO:0043654) |
0.0 | 0.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.0 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.0 | 0.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.0 | GO:0060459 | extraocular skeletal muscle development(GO:0002074) subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) prolactin secreting cell differentiation(GO:0060127) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.0 | 0.0 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.0 | 0.2 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.4 | GO:0001649 | osteoblast differentiation(GO:0001649) |
0.0 | 0.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.4 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 1.3 | GO:0016358 | dendrite development(GO:0016358) |
0.0 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.3 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.6 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 0.1 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.2 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.4 | GO:0006625 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.7 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.0 | 0.1 | GO:1904647 | response to rotenone(GO:1904647) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 1.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.3 | GO:0043066 | negative regulation of apoptotic process(GO:0043066) |
0.0 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.5 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.0 | 0.4 | GO:0006935 | chemotaxis(GO:0006935) taxis(GO:0042330) |
0.0 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 1.9 | GO:0008064 | regulation of actin polymerization or depolymerization(GO:0008064) |
0.0 | 0.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 1.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) mitotic G1/S transition checkpoint(GO:0044819) |
0.0 | 0.3 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.0 | 0.8 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0035904 | aorta development(GO:0035904) |
0.0 | 0.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.1 | GO:0021543 | pallium development(GO:0021543) |
0.0 | 0.3 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.0 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.0 | 0.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.0 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.0 | 0.7 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.0 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.4 | 26.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 1.2 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.4 | 1.1 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.3 | 1.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.0 | GO:0035841 | new growing cell tip(GO:0035841) |
0.3 | 1.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.3 | 0.9 | GO:1990031 | pinceau fiber(GO:1990031) |
0.3 | 1.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 2.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 0.9 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.2 | 1.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.2 | 1.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 1.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 0.5 | GO:1990032 | parallel fiber(GO:1990032) |
0.2 | 2.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 1.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 8.9 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.6 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.7 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.3 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.2 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 1.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.4 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.3 | GO:0036452 | ESCRT I complex(GO:0000813) ESCRT complex(GO:0036452) |
0.1 | 1.3 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 1.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.8 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.2 | GO:0070985 | TFIIK complex(GO:0070985) |
0.0 | 0.7 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 1.0 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 2.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.0 | 0.8 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.3 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.1 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 2.3 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.2 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.0 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 2.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.6 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 2.4 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.0 | 0.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 4.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 3.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 2.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 1.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 3.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 1.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.3 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 1.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 1.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 2.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.4 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 1.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 16.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.2 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 1.1 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 1.3 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.5 | 2.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 1.6 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.5 | 3.7 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.4 | 1.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.4 | 1.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 5.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 1.6 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.3 | 0.9 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.3 | 0.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 6.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.3 | 5.2 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.5 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.2 | 2.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 5.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.6 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.2 | 1.2 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.7 | GO:0005503 | all-trans retinal binding(GO:0005503) |
0.2 | 0.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.0 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.2 | 2.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 1.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.9 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 0.6 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.1 | 0.7 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 1.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 3.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.1 | 0.6 | GO:0042954 | apolipoprotein receptor activity(GO:0030226) lipoprotein transporter activity(GO:0042954) |
0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 3.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 1.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 0.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 1.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 1.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.9 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 1.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 1.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 1.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 1.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.6 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.5 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.2 | GO:0033677 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 1.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 1.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 17.1 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 3.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 1.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.2 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.1 | 0.7 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 1.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.1 | 2.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 1.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 1.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 1.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.2 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
0.1 | 0.3 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.1 | 0.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 1.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.1 | 0.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.6 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.0 | 0.9 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 1.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 3.9 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.7 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 2.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.2 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.0 | 0.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 5.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 1.3 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.0 | 0.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 0.5 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.1 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.0 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.3 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 1.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.0 | 0.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.0 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.0 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.2 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.6 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.5 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 2.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 2.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 22.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.0 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.0 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.0 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.0 | 0.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.1 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.0 | 0.2 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.0 | 2.3 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 1.2 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.1 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.1 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.0 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.0 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.0 | 0.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.0 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.0 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 3.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0034191 | GBD domain binding(GO:0032427) apolipoprotein A-I receptor binding(GO:0034191) GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 4.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 3.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 2.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 1.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 1.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 2.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 3.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 2.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 2.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 2.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 2.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 3.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 5.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 3.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 5.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 4.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 10.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 2.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 2.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 3.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 3.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 4.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 2.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 3.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 2.0 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 3.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 2.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 1.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 3.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 2.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.5 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.0 | 1.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 1.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 2.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 2.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 4.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 1.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |